Proline metabolism and cancer.

Proline plays a special role in cancer metabolism. Proline oxidase (POX), a.k.a. proline dehydrogenase (PRODH), is among a few genes induced rapidly and robustly by P53, the tumor suppressor. Ectopic expression of POX under control of tet-off promoter initiated mitochondrial apoptosis. The mechanism activated by POX is mediated by its production of ROS. In immunodeficient mice, POX overexpression markedly retarded growth of xenograft tumors. In human tumors of the digestive tract and kidney, POX was markedly decreased, suggesting that the suppressive effect of POX was downregulated. This was not due to POX gene mutations or hypermethylation. Instead, a microRNA, miR-23b*, expressed at high levels in tumors, was a potent inhibitor of POX expression. Furthermore, antagomirs of miR-23b* reversed the downregulated expression of POX and its tumor-suppressive effect, thereby providing a therapeutic strategy. POX not only responds to genotoxic stress, but also to inflammatory and metabolic stress. Depending on microenvironmental and temporal factors, POX can mediate oppositely-directed responses-programmed cell death, on the one hand, and survival, on the other.

[1]  C. Dang.  Oncogenic alterations of metabolism , 2014 .

[2]  Eva E. Rufino-Palomares,et al.  MicroRNAs as Oncogenes and Tumor Suppressors , 2013 .

[3]  K. Wellen,et al.  Cellular metabolic stress: considering how cells respond to nutrient excess. , 2010, Molecular cell.

[4]  Brian O'Rourke,et al.  Hypoxic tumor microenvironments reduce collagen I fiber density. , 2010, Neoplasia.

[5]  Wei Liu,et al.  Proline metabolism and microenvironmental stress. , 2010, Annual review of nutrition.

[6]  M. Nickerson,et al.  MicroRNA-23b* targets proline oxidase, a mitochondrial tumor suppressor protein in renal cancer , 2010, Oncogene.

[7]  A. Giaccia,et al.  Hypoxia, inflammation, and the tumor microenvironment in metastatic disease , 2010, Cancer and Metastasis Reviews.

[8]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[9]  A. Mobasheri,et al.  Targeting matrix metalloproteinases in inflammatory conditions. , 2009, Current drug targets.

[10]  Wei Liu,et al.  Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy , 2009, Carcinogenesis.

[11]  Joachim Selbig,et al.  Metabolic profiling reveals key metabolic features of renal cell carcinoma , 2009, Journal of cellular and molecular medicine.

[12]  C. Dang.  MYC, microRNAs and glutamine addiction in cancers , 2009, Cell cycle.

[13]  Harry Martin.  Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. , 2009, Mutation research.

[14]  Kevin W. Eliceiri,et al.  Matrix density-induced mechanoregulation of breast cell phenotype, signaling, and gene expression through a FAK-ERK linkage , 2009, Oncogene.

[15]  E. White,et al.  The Double-Edged Sword of Autophagy Modulation in Cancer , 2009, Clinical Cancer Research.

[16]  Peter Nürnberg,et al.  Mutations in PYCR1 cause cutis laxa with progeroid features , 2009, Nature Genetics.

[17]  Hanna Y. Irie,et al.  Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.

[18]  M. Anver,et al.  Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. , 2009, Cancer research.

[19]  Ichiro Takada,et al.  Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis , 2009, Nature Reviews Rheumatology.

[20]  J. Phang,et al.  Regulation and function of proline oxidase under nutrient stress , 2009, Journal of cellular biochemistry.

[21]  M. Tomita,et al.  Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. , 2009, Cancer research.

[22]  Y. Liu,et al.  Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers , 2008, Oncogene.

[23]  J. Phang,et al.  The metabolism of proline as microenvironmental stress substrate. , 2008, The Journal of nutrition.

[24]  G. Jenkins.  The role of proteases in transforming growth factor-beta activation. , 2008, The international journal of biochemistry & cell biology.

[25]  J. Phang,et al.  A Novel Function for Hydroxyproline Oxidase in Apoptosis through Generation of Reactive Oxygen Species* , 2008, Journal of Biological Chemistry.

[26]  J. Phang,et al.  The metabolism of proline, a stress substrate, modulates carcinogenic pathways , 2008, Amino Acids.

[27]  J. Tanner.  Structural biology of proline catabolism , 2008, Amino Acids.

[28]  Ralph J Deberardinis,et al.  Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.

[29]  Sang-Oh Yoon,et al.  Pro‐MMP‐2 activation by the PPARγ agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK , 2007, FEBS letters.

[30]  David M Sabatini,et al.  Defining the role of mTOR in cancer. , 2007, Cancer cell.

[31]  J. Tanner,et al.  Structure and Kinetics of Monofunctional Proline Dehydrogenase from Thermus thermophilus* , 2007, Journal of Biological Chemistry.

[32]  S. Hammond.  MicroRNAs as tumor suppressors , 2007, Nature Genetics.

[33]  D. Boyd,et al.  Regulation of matrix metalloproteinase gene expression , 2007, Journal of cellular physiology.

[34]  E. White,et al.  Role of Autophagy in Cancer: Management of Metabolic Stress , 2007, Autophagy.

[35]  M. Rocco,et al.  Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family , 2006, Journal of Medical Genetics.

[36]  Y. Liu,et al.  Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling , 2006, Oncogene.

[37]  M. Bissell,et al.  Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. , 2006, Annual review of cell and developmental biology.

[38]  J. Phang,et al.  Proline Oxidase, a Proapoptotic Gene, Is Induced by Troglitazone , 2006, Journal of Biological Chemistry.

[39]  L. Coussens,et al.  Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.

[40]  D. Sabatini,et al.  Redox Regulation of the Nutrient-sensitive Raptor-mTOR Pathway and Complex* , 2005, Journal of Biological Chemistry.

[41]  Craig B. Thompson,et al.  Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.

[42]  L. Oberley,et al.  MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. , 2005, Carcinogenesis.

[43]  Z. Werb,et al.  Coevolution of cancer and stromal cellular responses. , 2005, Cancer cell.

[44]  William C. Parks,et al.  Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.

[45]  A. Rivera,et al.  Proline Oxidase Induces Apoptosis in Tumor Cells, and Its Expression Is Frequently Absent or Reduced in Renal Carcinomas* , 2003, The Journal of Biological Chemistry.

[46]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[47]  D. Valle,et al.  Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. , 2001, Cancer research.

[48]  R. Evans,et al.  Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.

[49]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[50]  A. Igamberdiev,et al.  Induction of glyoxylate cycle enzymes in rat liver upon food starvation , 1996, FEBS letters.

[51]  G. C. Yeh,et al.  Purified human erythrocyte pyrroline-5-carboxylate reductase. Preferential oxidation of NADPH. , 1989, The Journal of biological chemistry.

[52]  B. Marian,et al.  Dermal collagen metabolism during tumor promotion with 12-O-tetradecanoylphorbol-13-acetate in mouse skin. , 1985, Carcinogenesis.

[53]  D. Dexter,et al.  Response of a human colon adenocarcinoma (DLD-1) to X irradiation and mitomycin C in vivo. , 1983, International journal of radiation oncology, biology, physics.

[54]  C. Scriver,et al.  Familial hyperprolinemia, cerebral dysfunction and renal anomalies occurring in a family with hereditary nephropathy and deafness. , 1962, The New England journal of medicine.

[55]  B. Nielsen,et al.  The collagen receptor uPARAP/Endo180. , 2009, Frontiers in bioscience.

[56]  Harry Martin.  Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. , 2009, Mutation research.

[57]  Y. Hsieh,et al.  Regulation of human dihydrofolate reductase activity and expression. , 2008, Vitamins and hormones.

[58]  C. Obie,et al.  Overexpression of proline oxidase induces proline-dependent and mitochondria-mediated apoptosis , 2006, Molecular and Cellular Biochemistry.

[59]  A. C. Nicholson,et al.  CD36, oxidized LDL and PPAR gamma: pathological interactions in macrophages and atherosclerosis. , 2004, Vascular pharmacology.

[60]  James,et al.  Purified Human Erythrocyte Pyrroline-5-carboxylate Reductase , 2001 .

[61]  J. Phang.  The regulatory functions of proline and pyrroline-5-carboxylic acid. , 1985, Current topics in cellular regulation.

[62]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[63]  E. Adams.  Metabolism of proline and of hydroxyproline. , 1970, International review of connective tissue research.